Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats

Chemico-biological Interactions
Thangarasu RajakumarSubbaiyan Thilagavathi

Abstract

The present study aimed to investigate the dose response chemopreventive potential of allyl isothiocyanate (AITC) against 7,12-dimethylbenz(a)anthracene (DMBA) induced mammary carcinogenesis in female Sprague-Dawley rats. Mammary tumor was induced by a single dose of DMBA (25 mg/rat) injected subcutaneously near mammary gland. We observed reduced body weight and increased in total number of tumors, tumor incidence and tumor volume in DMBA-induced rats. We also observed decreased antioxidant status (SOD, CAT, GPX and GSH) and increased lipid peroxidation (TBARS and LOOH) in plasma and mammary tissues. Increased levels of CYP450, Cyt-b5 and decreased levels of phase II (GST and GR) biotransformation enzymes noticed in liver and mammary tissues of DMBA-induced rats. Further, increased levels of lipid profile (TC, TG, PL and FFA) and lipoprotein (LDL and VLDL) were noticed. Whereas, decreased level of HDL in plasma and decreased levels of PL and FFA in mammary tissue. Oral administration of AITC different doses (10, 20 and 40 mg/kg bw) inhibited the tumor incidence and restored levels of biochemical markers. Biochemical findings are supported by histopathological studies. These results suggested that AITC at a dose of 20 mg/kg bw s...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
May 1, 1975·Chemistry and Physics of Lipids·P Emmelot, R P Van Hoeven
Oct 1, 1990·Biochemical Pharmacology·R Chander, N K Kapoor
Aug 1, 1990·Environmental Health Perspectives·D W NebertA J Fornace
Jan 1, 1985·Methods in Enzymology·I Carlberg, B Mannervik
Jan 1, 1988·Journal of Cancer Research and Clinical Oncology·C C ZielinskiC Müller
Nov 1, 1987·Chemistry and Physics of Lipids·K Yagi
Sep 1, 1986·British Journal of Cancer·I A BaniJ W Dickerson
Jun 1, 1972·Analytical Biochemistry·A K Sinha
Feb 9, 1973·Science·J T RotruckW G Hoekstra
Jun 28, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·K FalholtW Falholt
Jul 29, 1994·Cancer Letters·E KökoğluH Baloğlu
Nov 14, 1997·Science·W K Hong, M B Sporn
Nov 23, 2000·Nature·T Finkel, N J Holbrook
Jan 4, 2001·Drug Metabolism Reviews·S S Hecht
Apr 12, 2001·Journal of Ethnopharmacology·L Davis, G Kuttan
Feb 15, 1963·Experientia·E BEUTLER, B M KELLY
Feb 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Suleyman AydinFrazilet Erman
Jul 13, 2004·International Journal of Food Microbiology·Il Shik ShinKinae Naohide
Sep 24, 2004·Basic & Clinical Pharmacology & Toxicology·Yun-Tao ZhangRong-Liang Zheng
Feb 1, 2006·Cell Biochemistry and Function·Derya Erten SenerMeral Torun
Oct 27, 2006·Chemico-biological Interactions·Ramar Perumal SamySavarimuthu Ignacimuthu
Dec 5, 2009·Molecular Nutrition & Food Research·Yuesheng Zhang
Jul 20, 2010·Cancer Investigation·Maria Tria TironaOscar Ballester
Jun 23, 2011·Journal of Cellular and Molecular Medicine·Anika Eva WagnerGerald Rimbach
Dec 21, 2011·Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer·Natarajan Nandakumar, Maruthaiveeran Periyasamy Balasubramanian

❮ Previous
Next ❯

Citations

Feb 4, 2016·Phytotherapy Research : PTR·Suresh Kathiresan, Annamalai Govindhan
Mar 27, 2016·Seminars in Cancer Biology·Min Ji BakNanjoo Suh
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Soha M HamdyAlshimaa M Amin
Sep 1, 2016·Frontiers in Nutrition·Francisco J BarbaMohamed Koubaa
Dec 8, 2016·Revista da Associação Médica Brasileira·Ana Maria Oliveira Ferreira da MataBenedito Borges da Silva
Dec 31, 2017·Molecular Nutrition & Food Research·Ahmad Faizal Abdull RazisCostas Ioannides
Jul 22, 2018·Toxicology Mechanisms and Methods·Uma SaminathanRajendran Jayaganesh
Jul 18, 2019·Drug Development Research·Jayaganesh RajendranSuganthi Subramaniyan
Mar 10, 2018·Current Drug Discovery Technologies·Surendra AgrawalPravina Gurjar
Apr 14, 2018·Indian Journal of Clinical Biochemistry : IJCB·Thangarasu RajakumarSubbaiyan Thilagavathi
May 16, 2017·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Thangarasu RajakumarKrishnaswamy Gunasekaran
Jun 7, 2017·Molecular and Cellular Biochemistry·Thangarasu RajakumarKrishnaswamy Gunasekaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.